Skip to main content
. 2022 May 10;13(2):335–350. doi: 10.1007/s13167-022-00279-0

Fig. 6.

Fig. 6

Multivariate survival analysis showed that male, over 60 years old, clinical stages III–IV, and high expression of SNRPB and HNRNPCL1, were risk factors for poor prognosis